ELIC — Elicera Therapeutics AB Share News
0.000.00%
Last trade - 00:00- SEK189.29m
- SEK171.42m
- SEK10.86m
Brief: Elicera Therapeutics Carries Out Rights Issue Of About SEK 73 Mln
Sweden's Elicera Therapeutics Q1 loss narrows, reports positive clinical progress
Brief: Elicera Therapeutics Q1 Operating Loss SEK 5.1 Mln
Brief: Elicera Therapeutics Gets Notice Of Allowance For Japanease Patent
Brief: Elicera Therapeutics Provides Update On CARMA Study
Brief: Elicera Updates On Preclinical CAR T-Cell Program ELC-401 For Glioblastoma
Sweden's Elicera Q4 operating loss widens
Brief: Elicera Therapeutics Q4 Dividend SEK 0
Brief: Elicera Therapeutics: Final Data From Phase I/IIa Trial
Brief: Elicera Therapeutics Q3 Adjusted EPS Sek 0.01
Brief: Elicera Therapeutics Q2 Operating Loss At SEK 2.89 Mln
Brief: Elicera Gives Update On Carma Study
Brief: Elicera Therapeutics Q1 Operating Loss Widens To SEK 8.1 Mln
Brief: Elicera Therapeutics Resolves On Directed Issue Of Over 1.5 Mln Shares
Brief: Elicera Therapeutics Gets Partial Payment Of EUR 500,000 From EIC
Brief: Elicera Therapeutics Q4 Oper Loss Narrows To SEK 2.9 Mln
Brief: Elicera Therapeutics Q4 Dividend SEK 0
Brief: Elicera Therapeutics Drug Candidate Gets Orphan Drug Designation In U.S.
Brief: Elicera Therapeutics Q2 Operating Loss Widens To Sek 5.8 Mln